WOCKHARDT | SUN PHARMA | WOCKHARDT/ SUN PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -10.9 | 52.8 | - | View Chart |
P/BV | x | 1.0 | 4.5 | 22.0% | View Chart |
Dividend Yield | % | 0.0 | 1.1 | - |
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
WOCKHARDT Mar-22 |
SUN PHARMA Mar-22 |
WOCKHARDT/ SUN PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 805 | 931 | 86.4% | |
Low | Rs | 253 | 593 | 42.7% | |
Sales per share (Unadj.) | Rs | 224.3 | 161.1 | 139.2% | |
Earnings per share (Unadj.) | Rs | -19.4 | 14.2 | -136.5% | |
Cash flow per share (Unadj.) | Rs | -2.2 | 23.1 | -9.6% | |
Dividends per share (Unadj.) | Rs | 0 | 10.00 | 0.0% | |
Avg Dividend yield | % | 0 | 1.3 | 0.0% | |
Book value per share (Unadj.) | Rs | 266.0 | 200.1 | 132.9% | |
Shares outstanding (eoy) | m | 144.03 | 2,399.34 | 6.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 2.4 | 4.7 | 49.9% | |
Avg P/E ratio | x | -27.3 | 53.7 | -50.9% | |
P/CF ratio (eoy) | x | -238.0 | 32.9 | -722.7% | |
Price / Book Value ratio | x | 2.0 | 3.8 | 52.2% | |
Dividend payout | % | 0 | 70.4 | 0.0% | |
Avg Mkt Cap | Rs m | 76,168 | 1,827,693 | 4.2% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 7,490 | 73,008 | 10.3% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 32,300 | 386,545 | 8.4% | |
Other income | Rs m | 200 | 14,374 | 1.4% | |
Total revenues | Rs m | 32,500 | 400,919 | 8.1% | |
Gross profit | Rs m | 1,150 | 53,150 | 2.2% | |
Depreciation | Rs m | 2,470 | 21,437 | 11.5% | |
Interest | Rs m | 2,990 | 1,274 | 234.8% | |
Profit before tax | Rs m | -4,110 | 44,813 | -9.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | -1,320 | 10,755 | -12.3% | |
Profit after tax | Rs m | -2,790 | 34,058 | -8.2% | |
Gross profit margin | % | 3.6 | 13.7 | 25.9% | |
Effective tax rate | % | 32.1 | 24.0 | 133.8% | |
Net profit margin | % | -8.6 | 8.8 | -98.0% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 25,890 | 350,150 | 7.4% | |
Current liabilities | Rs m | 32,070 | 172,006 | 18.6% | |
Net working cap to sales | % | -19.1 | 46.1 | -41.5% | |
Current ratio | x | 0.8 | 2.0 | 39.7% | |
Inventory Days | Days | 31 | 149 | 21.0% | |
Debtors Days | Days | 10 | 100 | 10.4% | |
Net fixed assets | Rs m | 50,810 | 318,882 | 15.9% | |
Share capital | Rs m | 720 | 2,399 | 30.0% | |
"Free" reserves | Rs m | 37,590 | 477,713 | 7.9% | |
Net worth | Rs m | 38,310 | 480,112 | 8.0% | |
Long term debt | Rs m | 3,550 | 2,299 | 154.4% | |
Total assets | Rs m | 76,700 | 669,032 | 11.5% | |
Interest coverage | x | -0.4 | 36.2 | -1.0% | |
Debt to equity ratio | x | 0.1 | 0 | 1,935.0% | |
Sales to assets ratio | x | 0.4 | 0.6 | 72.9% | |
Return on assets | % | 0.3 | 5.3 | 4.9% | |
Return on equity | % | -7.3 | 7.1 | -102.7% | |
Return on capital | % | -2.7 | 9.6 | -28.0% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 1.9 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | 624 | NA | - | |
Fx inflow | Rs m | 2,263 | 106,331 | 2.1% | |
Fx outflow | Rs m | 624 | 71,874 | 0.9% | |
Net fx | Rs m | 1,638 | 34,456 | 4.8% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 4,130 | 89,845 | 4.6% | |
From Investments | Rs m | -2,010 | -57,247 | 3.5% | |
From Financial Activity | Rs m | -710 | -51,935 | 1.4% | |
Net Cashflow | Rs m | 1,380 | -17,648 | -7.8% |
Indian Promoters | % | 65.8 | 54.5 | 120.7% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 2.9 | 34.6 | 8.4% | |
FIIs | % | 2.8 | 15.0 | 18.8% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 34.3 | 45.5 | 75.2% | |
Shareholders | 180,170 | 647,167 | 27.8% | ||
Pledged promoter(s) holding | % | 47.8 | 4.0 | 1,184.2% |
Compare WOCKHARDT With: DR. REDDYS LAB CIPLA ZYDUS LIFESCIENCES AUROBINDO PHARMA LUPIN
After opening the day on a flat note, Indian share markets turned volatile during the afternoon session and fell hard as selling was seen in banking and auto stocks.